Transplant and immunosuppressant denials
Solid-organ transplant patients depend on continuous immunosuppressive therapy to prevent rejection. UNOS/OPTN guidelines establish that immunosuppressant regimens generally cannot be switched without significant clinical risk. Denials of transplant evaluation, listing, surgery, or maintenance immunosuppression are among the most clinically urgent appeals.
The rule that controls this: UNOS/OPTN clinical guidelines govern eligibility and continuity of care; Medicare Part B covers post-transplant immunosuppressants by statute.
Last reviewed 13 September 2026 · General information, not legal or medical advice · Apellica is not a law firm
What gets denied
- Transplant evaluation and waitlisting
- Transplant surgery (kidney, liver, heart, lung)
- Specific brand of immunosuppressant (tacrolimus, mycophenolate, sirolimus)
- Generic-to-brand switches denied
- Anti-rejection biologic therapy
- Out-of-network transplant centers
Common denial reasons
- Plan claims patient not medically eligible for transplant
- Step therapy on immunosuppressants
- Plan formulary forces switch from brand to generic
- Out-of-network transplant facility
- Post-transplant complications denied as unrelated
How we approach the appeal
Cite UNOS/OPTN clinical guidelines for transplant eligibility and continuity of care. For immunosuppressant switch denials, attach the treating transplant team's letter documenting the rejection risk from any regimen change. Many plans have specific transplant carve-out networks (Centers of Excellence), confirm in-network status of the specific center before assuming OON. Medicare Part B covers immunosuppressants post-transplant under federal law.
Urgent appeals: 72 hours. Standard: 30 days for prior auth, 60-180 days filing window. Transplant cases routinely qualify for expedited urgent review.
$10,000 - $1,000,000+
- · Denial letter
- · Transplant team's letter and treatment plan
- · UNOS / center listing documentation
- · Lab values supporting transplant indication
- · Prior immunosuppressant trial history (if relevant)
Transplant and immunosuppressant denial? Let's appeal it.
Two-minute micro intake. We confirm fit and reply within one business day with the right path for your situation.
Transplant denials by insurer
What each plan tends to cite, and the rule that controls it.
- UHC transplant denials
- Aetna transplant denials
- Cigna transplant denials
- BCBS transplant denials
- Humana transplant denials
- Medicare transplant denials
- Kaiser transplant denials
- Ambetter transplant denials
- Molina transplant denials
- BCBS FEP transplant denials
- TRICARE transplant denials
- WellCare transplant denials
This page provides general information about appeal strategy. It is not legal advice. Outcomes depend on documentation, plan terms, and timing.